US2012109023A1PendingUtilityA1
Systems and methods to target blood vessel adventitia with transcutaneous focused ultrasound
Est. expiryOct 20, 2025(expired)· nominal 20-yr term from priority
A61B 2090/372A61B 8/0833A61B 2090/3958A61F 2/82A61N 7/02A61B 17/0057A61B 2017/00637A61B 2090/3929A61B 2090/397A61B 18/02A61B 8/445A61B 50/13A61M 25/10A61B 8/12A61B 2017/00641A61B 34/25A61B 2090/3784A61B 5/026A61B 8/0841A61B 8/4405A61B 2017/00557
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Systems and methods for maintaining the alignment of a therapeutic ultrasound applicator to a target site are described. Overlapping ultrasound signals are sent to a target tissue site and the echo detected. An algorithm is described for detecting tissue movement relative to the applicator based on comparison of the echo with a previously stored echo.
Claims
exact text as granted — not AI-modified1 . A method of applying therapeutic energy to a target region comprising a blood vessel, the method comprising:
emitting first ultrasonic pulses from at least three ultrasound transducers to tissue at a target point within the target region, wherein the target point comprises the adventitia of a blood vessel; detecting first ultrasonic echoes from the blood vessel with the ultrasound transducers; emitting second ultrasonic pulses from the ultrasound transducers; detecting second ultrasonic echoes from the blood vessel with the ultrasound transducers; comparing the first and second ultrasonic echoes to determine time shifts or phase differences between the first and second ultrasonic echoes; determining the amount of relative tissue movement using the time shifts or phase differences and pre-determined unit vectors of each ultrasound transducer; adjusting a focus of a therapeutic ultrasound applicator based at least in part on the determined amount of relative tissue movement to keep the target point within the focus of the therapeutic applicator; and emitting a dose of therapeutic ultrasonic energy from the therapeutic ultrasound applicator such that the target point is exposed to the dose.
2 . The method of claim 1 , wherein determining the amount of relative tissue movement comprises executing a recursive algorithm.
3 . The method of claim 1 , wherein the predetermined unit vectors are determined experimentally.
4 . The method of claim 1 , wherein the therapeutic applicator comprises at least one of the ultrasound transducers.
5 . A method of applying focused ultrasound therapeutic energy, the method comprising:
emitting a first ultrasonic pulse from a first ultrasound transducer through skin tissue to a target point within a target region, wherein the target point comprises the adventitia of a blood vessel, the first ultrasound transducer comprising an array of at least one therapeutic piezoelectric element; detecting a first ultrasonic echo from the blood vessel at one of the therapeutic piezoelectric elements of the first ultrasound transducer; emitting a second ultrasonic pulse from the first ultrasound transducer; detecting a second ultrasonic echo from the blood vessel at one of the therapeutic piezoelectric elements of the first ultrasound transducer; comparing the first and second echoes to determine time shifts or phase differences between the detected echoes; determining the position of the target point relative to the focus of the therapy using the time shifts or phase differences; adjusting a focus of a therapeutic ultrasound applicator based at least in part on the determined position to keep the target point within the focus of the therapeutic applicator; and emitting a dose of therapeutic ultrasonic energy from the therapeutic ultrasound applicator such that the target point is exposed to the dose.
6 . The method of claim 5 , further comprising detecting the ultrasonic echoes with at least one additional ultrasound transducer.
7 . The method of claim 6 wherein the additional ultrasound transducer does not contribute to therapy.
8 . The method of claim 6 wherein the additional ultrasound transducer is placed on the perimeter of the annular array.
9 . The method of claim 5 , further comprising detecting the amount of relative tissue motion between the first and second echoes.
10 . A method of applying therapeutic energy to a target region comprising a blood vessel, the method comprising:
emitting an ultrasonic pulse from a first ultrasound transducer to tissue at a target point within the target region, wherein the target point comprises the adventitia of a blood vessel; detecting a first ultrasonic echo from the target point; comparing the first echo to a previously recorded echo to determine time shifts or phase differences between the detected echoes and the previously recorded echoes; determining the amount of relative tissue movement using the time shifts or phase differences and pre-determined unit vectors of each ultrasound transducer; adjusting a focus of a therapeutic ultrasound applicator based at least in part on the determined amount of relative tissue movement to keep the target point within the focus of the therapeutic applicator; and emitting a dose of therapeutic ultrasonic energy from the therapeutic ultrasound applicator such that the target point is exposed to the dose.
11 . The method of claim 10 , further comprising detecting the ultrasonic echo with at least one additional ultrasound transducer.
12 . The method of claim 10 , wherein determining the amount of relative tissue movement comprises executing a recursive algorithm.
13 . The method of claim 10 , wherein the predetermined unit vectors are determined experimentally.
14 . The method of claim 10 , wherein the therapeutic applicator comprises the first ultrasound transducer.
15 . The method of claim 10 , wherein the first ultrasound transducer comprises a piezoelectric element adapted exclusively to transmit imaging ultrasonic pulses.Join the waitlist — get patent alerts
Track US2012109023A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.